D-0507-2019 Class II Terminated
FDA drug recall D-0507-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 31, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out of specification results observed for high dissolution. The recall status is terminated (terminated Feb 14, 2023). Affected quantity: 10,656 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 27, 2019
- Initiation Date
- Jan 31, 2019
- Termination Date
- Feb 14, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,656 bottles
Product description
Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01
Reason for recall
Failed Dissolution Specifications: Out of specification results observed for high dissolution.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: C802676, Exp 03/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0507-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026